Organon & Co. (BMV:OGN)

Organon & Co. Statistics

Total Valuation

Organon & Co. has a market cap or net worth of MXN 33.77 billion. The enterprise value is 182.17 billion.

Market Cap	33.77B
Enterprise Value	182.17B

Important Dates

The next estimated earnings date is Thursday, February 12, 2026.

Earnings Date	Feb 12, 2026
Ex-Dividend Date	Nov 20, 2025

Share Statistics

Current Share Class	259.98M
Shares Outstanding	n/a
Shares Change (YoY)	+0.81%
Shares Change (QoQ)	+0.19%
Owned by Insiders (%)	0.41%
Owned by Institutions (%)	77.94%
Float	258.67M

Valuation Ratios

The trailing PE ratio is 3.68 and the forward PE ratio is 1.89.

PE Ratio	3.68
Forward PE	1.89
PS Ratio	0.29
PB Ratio	2.03
P/TBV Ratio	n/a
P/FCF Ratio	2.37
P/OCF Ratio	1.94
PEG Ratio	n/a

Enterprise Valuation

The stock's EV/EBITDA ratio is 5.71, with an EV/FCF ratio of 12.78.

EV / Earnings	19.82
EV / Sales	1.59
EV / EBITDA	5.71
EV / EBIT	7.43
EV / FCF	12.78

Financial Position

The company has a current ratio of 1.75, with a Debt / Equity ratio of 9.74.

Current Ratio	1.75
Quick Ratio	0.82
Debt / Equity	9.74
Debt / EBITDA	5.04
Debt / FCF	11.36
Interest Coverage	2.62

Financial Efficiency

Return on equity (ROE) is 71.62% and return on invested capital (ROIC) is 8.87%.

Return on Equity (ROE)	71.62%
Return on Assets (ROA)	6.40%
Return on Invested Capital (ROIC)	8.87%
Return on Capital Employed (ROCE)	12.39%
Revenue Per Employee	11.56M
Profits Per Employee	918,944
Employee Count	10,000
Asset Turnover	0.48
Inventory Turnover	1.95

Taxes

In the past 12 months, Organon & Co. has paid 3.69 billion in taxes.

Income Tax	3.69B
Effective Tax Rate	28.63%

Stock Price Statistics

The stock price has decreased by -61.22% in the last 52 weeks.

Beta (5Y)	n/a
52-Week Price Change	-61.22%
50-Day Moving Average	171.31
200-Day Moving Average	428.90
Relative Strength Index (RSI)	39.41
Average Volume (20 Days)	2,725

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	2.80

Income Statement

In the last 12 months, Organon & Co. had revenue of MXN 115.57 billion and earned 9.19 billion in profits. Earnings per share was 35.07.

Revenue	115.57B
Gross Profit	64.34B
Operating Income	24.71B
Pretax Income	12.88B
Net Income	9.19B
EBITDA	30.98B
EBIT	24.71B
Earnings Per Share (EPS)	35.07

Balance Sheet

The company has 12.33 billion in cash and 161.92 billion in debt, giving a net cash position of -149.60 billion.

Cash & Cash Equivalents	12.33B
Total Debt	161.92B
Net Cash	-149.60B
Net Cash Per Share	n/a
Equity (Book Value)	16.62B
Book Value Per Share	63.92
Working Capital	37.07B

Cash Flow

In the last 12 months, operating cash flow was 17.41 billion and capital expenditures -3.15 billion, giving a free cash flow of 14.25 billion.

Operating Cash Flow	17.41B
Capital Expenditures	-3.15B
Free Cash Flow	14.25B
FCF Per Share	n/a

Margins

Gross margin is 55.67%, with operating and profit margins of 21.38% and 7.95%.

Gross Margin	55.67%
Operating Margin	21.38%
Pretax Margin	11.14%
Profit Margin	7.95%
EBITDA Margin	26.81%
EBIT Margin	21.38%
FCF Margin	12.33%

Dividends & Yields

This stock pays an annual dividend of 6.83, which amounts to a dividend yield of 5.13%.

Dividend Per Share	6.83
Dividend Yield	5.13%
Dividend Growth (YoY)	-66.64%
Years of Dividend Growth	1
Payout Ratio	31.54%
Buyback Yield	-0.81%
Shareholder Yield	4.32%
Earnings Yield	27.21%
FCF Yield	42.20%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value
Lynch Upside
Graham Number
Graham Upside

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Organon & Co. has an Altman Z-Score of 1.27 and a Piotroski F-Score of 5. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	1.27
Piotroski F-Score	5